140 related articles for article (PubMed ID: 32721100)
21. Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP).
Fuster JL; Molinos-Quintana A; Fuentes C; Fernández JM; Velasco P; Pascual T; Rives S; Dapena JL; Sisinni L; López-Godino O; Palomo P; Villa-Alcázar M; Bautista F; González-Vicent M; López-Duarte M; García-Morín M; Ramos-Elbal E; Ramírez M;
Br J Haematol; 2020 Sep; 190(5):764-771. PubMed ID: 32314348
[TBL] [Abstract][Full Text] [Related]
22. Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Patrick K; Wade R; Goulden N; Mitchell C; Moorman AV; Rowntree C; Jenkinson S; Hough R; Vora A
Br J Haematol; 2014 Aug; 166(3):421-4. PubMed ID: 24708207
[TBL] [Abstract][Full Text] [Related]
23. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
24. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
[TBL] [Abstract][Full Text] [Related]
25. Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Groeneveld-Krentz S; Schroeder MP; Reiter M; Pogodzinski MJ; Pimentel-Gutiérrez HJ; Vagkopoulou R; Hof J; Chen-Santel C; Nebral K; Bradtke J; Türkmen S; Baldus CD; Gattenlöhner S; Haas OA; von Stackelberg A; Karawajew L; Eckert C; Kirschner-Schwabe R
Br J Haematol; 2019 Apr; 185(2):266-283. PubMed ID: 30714092
[TBL] [Abstract][Full Text] [Related]
26. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
Topp MS; Gökbuget N; Stein AS; Zugmaier G; O'Brien S; Bargou RC; Dombret H; Fielding AK; Heffner L; Larson RA; Neumann S; Foà R; Litzow M; Ribera JM; Rambaldi A; Schiller G; Brüggemann M; Horst HA; Holland C; Jia C; Maniar T; Huber B; Nagorsen D; Forman SJ; Kantarjian HM
Lancet Oncol; 2015 Jan; 16(1):57-66. PubMed ID: 25524800
[TBL] [Abstract][Full Text] [Related]
27. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.
Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y;
Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853
[TBL] [Abstract][Full Text] [Related]
28. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
[TBL] [Abstract][Full Text] [Related]
29. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.
Uyttebroeck A; Suciu S; Laureys G; Robert A; Pacquement H; Ferster A; Marguerite G; Mazingue F; Renard M; Lutz P; Rialland X; Mechinaud F; Cavé H; Baila L; Bertrand Y;
Eur J Cancer; 2008 Apr; 44(6):840-6. PubMed ID: 18342502
[TBL] [Abstract][Full Text] [Related]
30. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.
Sun W; Malvar J; Sposto R; Verma A; Wilkes JJ; Dennis R; Heym K; Laetsch TW; Widener M; Rheingold SR; Oesterheld J; Hijiya N; Sulis ML; Huynh V; Place AE; Bittencourt H; Hutchinson R; Messinger Y; Chang B; Matloub Y; Ziegler DS; Gardner R; Cooper T; Ceppi F; Hermiston M; Dalla-Pozza L; Schultz KR; Gaynon P; Wayne AS; Whitlock JA
Leukemia; 2018 Nov; 32(11):2316-2325. PubMed ID: 29728694
[TBL] [Abstract][Full Text] [Related]
31. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy.
Rivera GK; Raimondi SC; Hancock ML; Behm FG; Pui CH; Abromowitch M; Mirro J; Ochs JS; Look AT; Williams DL
Lancet; 1991 Jan; 337(8733):61-6. PubMed ID: 1670723
[TBL] [Abstract][Full Text] [Related]
32. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
[TBL] [Abstract][Full Text] [Related]
33. [T-cell pediatric acute lymphoblastic leukemia: analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP].
Rives S; Estella J; Camós M; García-Miguel P; Verdeguer A; Couselo JM; Tasso M; Molina J; Gómez P; Fernández-Delgado R; Navajas A; Badell I;
Med Clin (Barc); 2012 Jul; 139(4):141-9. PubMed ID: 22459573
[TBL] [Abstract][Full Text] [Related]
34. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
35. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
36. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
37. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
38. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract][Full Text] [Related]
39. A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma.
Zhu MY; Wang H; Huang CY; Xia ZJ; Chen XQ; Geng QR; Wang WD; Wang L; Lu Y
Oncotarget; 2016 Jun; 7(25):38884-38891. PubMed ID: 27150061
[TBL] [Abstract][Full Text] [Related]
40. Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.
Szczepanek J; Pogorzala M; Konatkowska B; Juraszewska E; Badowska W; Olejnik I; Kuzmicz M; Stanczak E; Malinowska I; Stefaniak J; Sobol G; Szczepanski T; Czyzewski K; Wysocki M; Styczynski J
Anticancer Res; 2010 Jun; 30(6):2119-24. PubMed ID: 20651360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
